Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

<table>Trichomegaly. Trichomegaly developed in a 40-year-old woman, 3 months preceding erlotinib. Notice the wavy, curly, and aberrant elongation of the eyelashes.</table>

Dermatology Research and Practice

fig3

Figure 3

Figure 3: Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management 